Join the industry in Barcelona | 7 - 9 September 2026 for 3 days of deal-making, data-driven insight and serious momentum across cell and gene therapy. From early science to commercial scale, this is where the full ecosystem connects, collaborates and moves the field forward.
NKILT Therapeutics brings a novel off-the-shelf cell therapy to tackle over half of cancers across hematologic and solid tumors.